Published in Zentralbl Bakteriol Orig on August 01, 1965
Antibacterial sensitivity of Bifidobacterium (Lactobacillus bifidus). J Bacteriol (1967) 2.21
Multiple-dose pharmacokinetics of ceftazidime and its influence on fecal flora. Antimicrob Agents Chemother (1983) 1.39
Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora. Antimicrob Agents Chemother (1986) 1.20
Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection (1984) 7.53
Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother (1985) 5.74
Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins. Antimicrob Agents Chemother (1983) 5.16
The negative regulator of beta-lactamase induction AmpD is a N-acetyl-anhydromuramyl-L-alanine amidase. FEMS Microbiol Lett (1994) 2.60
Amikacin resistance mediated by multiresistance transposon Tn2424. J Bacteriol (1983) 2.15
Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli. Antimicrob Agents Chemother (1999) 1.99
Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis. Thorax (2009) 1.90
Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin. Antimicrob Agents Chemother (1988) 1.88
The signal molecule for beta-lactamase induction in Enterobacter cloacae is the anhydromuramyl-pentapeptide. Antimicrob Agents Chemother (1997) 1.84
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia. Antimicrob Agents Chemother (2001) 1.74
Insertions of resistance genes into Tn21-like transposons. J Antimicrob Chemother (1986) 1.70
Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation. Antimicrob Agents Chemother (2007) 1.63
From registry to quality management: the German Cystic Fibrosis Quality Assessment project 1995 2006. Eur Respir J (2007) 1.61
HR 810, a cephalosporin with low affinity for Enterobacter cloacae beta-lactamase. Eur J Clin Microbiol (1983) 1.59
Molecular nature of a streptomycin and sulfonamide resistance plasmid (pBP1) prevalent in clinical Escherichia coli strains and integration of an ampicillin resistance transposon (TnA). Antimicrob Agents Chemother (1981) 1.58
Characterization of Tn2411 and Tn2410, two transposons derived from R-plasmid R1767 and related to Tn2603 and Tn21. J Bacteriol (1983) 1.57
[Stability of coli flora of the healthy human. 1. The occurrence of permanent and changing types]. Arch Hyg Bakteriol (1969) 1.49
The effect of a combined preparation of trimethoprim and sulphamethoxazole following short-term and long-term administration on the flora of the human gut. Chemotherapy (1973) 1.45
Use of a broad-host-range gyrA plasmid for genetic characterization of fluoroquinolone-resistant gram-negative bacteria. Antimicrob Agents Chemother (1991) 1.42
Transfer of gentamicin resistance from Pseudomonas aeruginosa strains highly resistant to gentamicin and carbenicillin. Chemotherapy (1973) 1.41
Multiple-dose pharmacokinetics of ceftazidime and its influence on fecal flora. Antimicrob Agents Chemother (1983) 1.39
Sequences of wild-type and mutant ampD genes of Citrobacter freundii and Enterobacter cloacae. Antimicrob Agents Chemother (1993) 1.34
Prospective evaluation of emerging bacteria in cystic fibrosis. J Cyst Fibros (2005) 1.33
Beta-lactam antibiotics and selection of resistance: speculation on the evolution of R-plasmids. J Antimicrob Chemother (1986) 1.32
[Antibacterial activity of mezlocillin and azlocillin/A survey (author's transl)]. Arzneimittelforschung (1979) 1.29
Evolution of Tn21-related transposons: isolation of Tn2425, which harbours IS161. J Gen Microbiol (1985) 1.24
[Ampicillin, pivampicillin and amoxycillin. Comparative studies on serum concentrations and urinary excretion after oral administration to fasting subjects]. Arzneimittelforschung (1974) 1.23
Genetic control of beta-lactamase production in Enterobacter cloacae. Rev Infect Dis (1988) 1.21
Tn21-specific structures in gram-negative bacteria from clinical isolates. Antimicrob Agents Chemother (1992) 1.20
Natural antibiotic susceptibility of Providencia stuartii, P. rettgeri, P. alcalifaciens and P. rustigianii strains. J Med Microbiol (1998) 1.19
Natural antibiotic susceptibility of Enterobacter amnigenus, Enterobacter cancerogenus, Enterobacter gergoviae and Enterobacter sakazakii strains. Clin Microbiol Infect (2002) 1.19
[Respiratory tract infections--clinical results with ofloxacin]. Infection (1986) 1.18
Impact of the ampD gene and its product on beta-lactamase production in Enterobacter cloacae. Rev Infect Dis (1988) 1.18
Natural antibiotic susceptibility of Listeria species: L. grayi, L. innocua, L. ivanovii, L. monocytogenes, L. seeligeri and L. welshimeri strains. Clin Microbiol Infect (2000) 1.16
Characterization of aminoglycoside 6'-N-acetyltransferases [AAC(6')] from gram-negative bacteria and Streptomyces kanamyceticus. J Antimicrob Chemother (1985) 1.14
[The serum and uterine muscle concentrations of Cephradin and Cephalothin]. Geburtshilfe Frauenheilkd (1975) 1.10
Natural antibiotic susceptibility of Escherichia coli, Shigella, E. vulneris, and E. hermannii strains. Diagn Microbiol Infect Dis (1999) 1.10
Elimination of plasmids by new 4-quinolones. Antimicrob Agents Chemother (1985) 1.08
Mathematical corrections for bacterial loss in pharmacodynamic in vitro dilution models. Antimicrob Agents Chemother (1995) 1.07
Development of resistance in the past decade in central Europe. J Antimicrob Chemother (1986) 1.07
Natural antibiotic susceptibility of strains of Serratia marcescens and the S. liquefaciens complex: S. liquefaciens sensu stricto, S. proteamaculans and S. grimesii. Int J Antimicrob Agents (2003) 1.05
The effect of moxifloxacin on its target topoisomerases from Escherichia coli and Staphylococcus aureus. J Antimicrob Chemother (1999) 1.04
Functional and physiological characterization of the Tn21 cassette for resistance genes in Tn2426. J Gen Microbiol (1993) 1.04
The problems of drug-resistant pathogenic bacteria. Experimental and clinical aspects of resistance determinants. Structure and recipient ability in E. Coli mutants. Ann N Y Acad Sci (1971) 1.03
Chemical characterization and biological activity of Macfadyena unguis-cati (Bignoniaceae). J Pharm Pharmacol (2000) 1.03
The bacteriology of dentogenous pyogenic infections. Oral Surg Oral Med Oral Pathol (1981) 1.03
Location of N-acetylmuramyl-L-alanyl-D-glutamylmesodiaminopimelic acid, presumed signal molecule for beta-lactamase induction, in the bacterial cell. Antimicrob Agents Chemother (1996) 1.03
Modifying effects of pH and temperature on (14C)erythromycin uptake into Staphylococcus aureus--relation to antimicrobial activity. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 1.02
Identification and natural antibiotic susceptibility of Morganella morganii. Diagn Microbiol Infect Dis (1998) 1.00
R factor-mediated resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa. Jpn J Microbiol (1975) 0.99
Transposition of a gene encoding OXA-2 beta-lactamase. J Gen Microbiol (1983) 0.98
Antibiotic therapy of chronic post-traumatic osteomyelitis. J Bone Joint Surg Br (1974) 0.98
[The propagation of aminoglycoside transferases in gram negative bacteria]. Int J Clin Pharmacol Biopharm (1979) 0.97
Kinetics of erythromycin uptake and release by human lymphocytes and polymorphonuclear leucocytes. J Antimicrob Chemother (1986) 0.97
Natural antimicrobial susceptibility patterns and biochemical profiles of Leclercia adecarboxylata strains. Clin Microbiol Infect (2004) 0.96
Pharmakokinetics of erythromycin. Scott Med J (1977) 0.96
Mechanisms of antibiotic resistance and their dissemination of resistance genes in the hospital environment. Infect Control (1984) 0.95
An in-vitro study of the antimicrobial susceptibilities of Yersinia enterocolitica and the definition of a database. J Antimicrob Chemother (1999) 0.95
Impact of oral ciprofloxacin on the faecal flora of healthy volunteers. Infection (1986) 0.94
[Bacteriological and virological studies on the human infections transmitted by monkeys in Frankfurt/M]. Dtsch Med Wochenschr (1968) 0.93
[The transmission of R factors in the human intestinal flora]. Zentralbl Bakteriol Orig (1970) 0.93
Natural antibiotic susceptibility of Salmonella enterica strains. Int J Antimicrob Agents (2000) 0.93
Occurrence of aminoglycoside-modifying enzymes in resistant strains of enterobacteria and Pseudomonas aeruginosa from several countries. J Antimicrob Chemother (1981) 0.93
Serotyping, sites of isolation and resistance of Pseudomonas aeruginosa. Microbiologica (1988) 0.92
The activity of cefotiam on beta-lactamase-producing bacteria in an in-vitro model. J Antimicrob Chemother (1984) 0.92
Antimicrobial effects of continuous versus intermittent administration of carbapenem antibiotics in an in vitro dynamic model. Antimicrob Agents Chemother (1997) 0.91
Natural antibiotic susceptibility of Rahnella aquatilis and R. aquatilis-related strains. J Chemother (2000) 0.91
Dissemination of streptomycin and sulfonamide resistance by plasmid pBP1 in Escherichia coli. Eur J Clin Microbiol (1983) 0.90
Role of penicillin-binding proteins in the initiation of the AmpC beta-lactamase expression in Enterobacter cloacae. Antimicrob Agents Chemother (2000) 0.89
[The COMOD system. A preservative-free multidose container for eyedrops]. Klin Monbl Augenheilkd (1994) 0.88
Antibiotic resistance in intensive care unit areas. Infect Control (1983) 0.88
[Acute pain management in proximal femoral fractures: femoral nerve block (catheter technique) vs. systemic pain therapy using a clinic internal organisation model]. Anaesthesist (2006) 0.87
Transfer of the chromosomal bla gene from Enterobacter cloacae to Escherichia coli by RP4::mini-Mu. J Bacteriol (1984) 0.87
[Fusidic acid concentrations in chronically inflamed tissue. Studies of chronic posttraumatic osteomyelitis]. Arzneimittelforschung (1966) 0.87
Application of in-vitro models: development of resistance. J Antimicrob Chemother (1985) 0.87
Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose. Infection (1997) 0.87
Prevalence of resistance of aerobic gram-negative bacilli to broad-spectrum antibacterial agents: results of a multicentre study. J Antimicrob Chemother (1990) 0.87
Studies on the nature of plasmids arising from conjugation in the human gastro-intestinal tract. J Med Microbiol (1973) 0.87
Natural antibiotic susceptibility of Klebsiella pneumoniae, K. oxytoca, K. planticola, K. ornithinolytica and K. terrigena strains. J Med Microbiol (2001) 0.86
Inhibition of R-plasmid transfer in Escherichia coli by 4-quinolones. Antimicrob Agents Chemother (1987) 0.86
[The influence of pivmecillinam on the human gut flora (author's transl)]. Arzneimittelforschung (1976) 0.86
Mobilization of extrachromosomal determinants for streptomycin resistance by transferable colicinogenic factors. Ann N Y Acad Sci (1971) 0.86
Comparative in vitro activity, serum binding and binding activity interactions of the macrolides A-56268, RU-28965, erythromycin and josamycin. Drugs Exp Clin Res (1987) 0.86
The role of N-actylglucosaminyl-1,6 anhydro N-acetylmuramyl-L-alanyl-D-glutamyl-meso-diaminopimelic acid-D-alanine for the induction of beta-lactamase in Enterobacter cloacae. Zentralbl Bakteriol (1996) 0.86
Impact of injectable cephalosporins on the gastrointestinal microflora: observations in healthy volunteers and hospitalized patients. Infection (1985) 0.86
Cefotaxime concentration in cerebrospinal fluid. J Antimicrob Chemother (1980) 0.85
R plasmids coding for gentamicin, tobramycin, and carbenicillin resistance in Serratia, Klebsiella and Escherichia coli strains from a single clinical source. Chemotherapy (1977) 0.85
The use of bacteria producing the aminoglycoside inactivating enzyme ANT-(2") in an in-vitro model. J Antimicrob Chemother (1985) 0.85
Bacterial elimination and therapeutic effectiveness under different schedules of amoxicillin administration. Chemotherapy (1981) 0.85
Whole body tissue distribution of [14C]-erythromycin in the guinea pig. An autoradiographic study. Arzneimittelforschung (1987) 0.85
Flow cytometric analysis of nephroblastomas and related neoplasms. Cancer (1986) 0.85
Selection of beta-lactamase producers during cephalosporin and penicillin therapy. Scand J Infect Dis Suppl (1986) 0.85
The incidence and development of resistance in Staphylococcus aureus from three European countries. J Antimicrob Chemother (1984) 0.85
Genetic and biochemical basis of resistance of Enterobacteriaceae to beta-lactam antibiotics. J Antimicrob Chemother (1986) 0.83
Natural antibiotic susceptibilities of Edwardsiella tarda, E. ictaluri, and E. hoshinae. Antimicrob Agents Chemother (2001) 0.83
Treatment of chronic carriers of Salmonella typhi and Salmonella paratyphi B with trimethoprim-sulfamethoxazole. J Infect Dis (1973) 0.83
Expression of beta-lactamases in Yersinia enterocolitica strains of biovars 2, 4 and 5. J Med Microbiol (1999) 0.83